Filing Details
- Accession Number:
- 0001209191-20-050681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 16:01:08
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-16 16:01:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586892 | D Daniel Shoemaker | C/O Fate Therapeutics, Inc.; 3535 General Atomics Court #200 San Diego CA 92121 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-14 | 1,400 | $35.40 | 141,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-14 | 17,887 | $36.11 | 123,804 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-14 | 5,713 | $37.12 | 118,091 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020.
- Represents the weighted average sale price of the shares sold ranging from $34.68 to $35.67 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $35.68 to $36.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $36.69 to $37.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
